Bellataminal

Беллатаминал Drug photo

The description is actual on 03.06.2014

  • Latin name: Bellataminal
  • ATH code: N05CB02
  • Active ingredient: Belladonnas alkaloids, Phenobarbital and Ergotamine (Belladonna alkaloids, Phenobarbital, Ergotamine)
  • Producer: CJSC Farmtsentr VILLAR, Russia

Structure

Bellataminal contains several active agents – ergotamine tartrate, phenobarbital and alkaloids of a belladonna. And also excipients, for example: sucrose, starch, povidone, calcium stearate, silicon dioxide colloid, magnesium elements and so on.

Release form

Tablets, coated which can be offered in packagings on 10, 30 and 50 pieces.

Pharmacological action

This drug possesses the calming action.

Pharmacodynamics and pharmacokinetics

Bellataminal is the combined medicine which efficiency is defined by impact on a human body of each making component. Therefore ergotamine and alkaloids of a belladonna show small spasmolytic action. Phenobarbital reduces excitability of peripheral nerve terminations, thanks to existence of the calming effect.

Usually therapeutic effect is felt after long administration of drug – not less than one month. Bodies of secretory system are responsible for removal of medicine from an organism.

Indications to Bellataminal use

Other indications to use of tablets: concussion in complex treatment and the other diseases affecting brain activity.

Contraindications to Bellataminal use

Besides, patients need to consider that medicine is recommended to be taken with caution during driving of motor transport, occupation by the dangerous activity requiring high attention, the accelerated reaction and good sight.

Side effects

Reception of Bellataminal can cause dryness of an oral cavity, drowsiness and development of various allergic reactions.

Bellataminal, application instruction (Way and dosage)

Tablets are intended for internal reception – daily on one piece 2-3 times after food. As the application instruction of Bellataminal shows, the course of treatment in most cases makes 2-4 weeks, depending on complexity of a disease. Carrying out repeated therapy, according to the decision of the specialist is not excluded.

Wikipedia does not contain information on this drug.

Overdose

At overdose there is dizziness, the general slackness of an organism, tachycardia, paresis of accommodation, a problem with an urination, an intestines atony, convulsive and even a coma.

The recommended treatment: washing of a gastrointestinal tract, reception of absorbent carbon or other symptomatic therapy.

Interaction

The concomitant use of Bellataminal and oral contraceptives can reduce their efficiency. At the same time nicotine and adrenostimulyator increase sedative effect of drug.

Terms of sale

It is released according to the recipe of the specialist.

Storage conditions

Tablets need to be stored in the dry place protected from children where temperature does not exceed 25 °C.

Period of validity

At the correct storage it is possible to use drug 5 years.

Analogs of Bellataminal

Coincidence on the ATH code of the 4th level:

Popular analogs are Reladormum, Bellalgin and Bellasthesinum. Besides, there are vegetable means and sedative drugs of a synthetic origin – bromides, for example, of sodium or Kalii bromidums and Bromcamphora are developed. These components are accepted or independently, or are a part of some calmatives.

As for the cost of analogs, they can be got in drugstores with the broad price range – 82-250 rubles.

Alcohol and Bellataminal

Though in the instruction to drug interaction of Bellataminal and alcohol, but as clinical practice shows is not described, alcohol, as well as nicotine are capable to strengthen effect of this medicine.

Zdravzona

  • Bellataminal No. 30 tabletkifarmvilar FPK
to show still
Section: For a nervous system
PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Bellataminal surely consult with the attending physician.